| NCT Number | NCT05239858 |
| Lead Sponsor | Orphalan
Collaborators: Ergomed |
| Conditions | Wilson's Disease |
| Enrollment | 500 participants |
| Start Date | 2022-06-29 |
| Primary Completion | 2027-12 (estimated) |
| Study Completion | 2027-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-11 |